-+ 0.00%
-+ 0.00%
-+ 0.00%

United Therapeutics Chairperson, CEO Rothblatt sells 9,500 shares for $4.92 million

PUBT·08/26/2026 20:32:18
Listen to the news
United Therapeutics Chairperson, CEO Rothblatt sells 9,500 shares for $4.92 million
  • United Therapeutics Chairperson and CEO Martine A. Rothblatt exercised stock options for 9,500 shares at USD 135.42 on Aug. 25.
  • Family trusts sold 9,500 shares in multiple trades at weighted average prices near USD 516–520 on the same day.
  • Holdings in the reported trust ended at 324,443 shares following the transactions.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-26-000128), on August 26, 2026, and is solely responsible for the information contained therein.